| |
TTD
Drug ID:
DAP000836
| Drug
Information |
| Name | Tridihexethyl | | Synonyms | NCGC00179360-01; Prestwick2_001042; BPBio1_001062; Prestwick1_001042; SPBio_002902; AC1Q76YT; BSPBio_000964; C07861; CID20299; Tridihexethyl; 3-cyclohexyl-N,N,N-triethyl-3-hydroxy-3-phenylpropan-1-aminium; Pathilon; Prestwick0_001042; CHEBI:9701; AC1L2FZA; AB00514015; UNII-7HE50A367X; 60-49-1; Benzenepropanaminium, gamma-cyclohexyl-N,N,N-triethyl-gamma-hydroxy-; L001320; (3-cyclohexyl-3-hydroxy-3-phenylpropyl)-triethylazanium; Prestwick3_001042; 4310-35-4 (chloride); Propethonum; 125-99-5 (iodide); DB00505 | | Indication | Acquired nystagmus | Approved [1] | | Structure |
Click to save drug structure in 3D MOL format
Click to save drug structure in 2D MOL format | | Therapeutic Class | Anticholinergic Agents | | CAS Number | CAS 60-49-1 | | Formular | C21H36NO | | PubChem Compound ID | CID 20299. | | PubChem Substance ID | SID 10063. | | ChEBI | 9701; | | SuperDrug ATC ID | A03AB08; | | SuperDrug CAS ID | 000060491; | | Target | Muscarinic acetylcholine receptor |  | Binder | [2] | | Ref 1 | FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 009489 To Reference | | Ref 2 | Effect of anticholinergic agents upon acquired nystagmus: a double-blind study of trihexyphenidyl and tridihexethyl chloride. Neurology. 1991 Nov;41(11):1737-41. To Reference |
Welcome
to sign our Guestbook.
If you
find any error in data or bug in web service, please kindly report it
to Dr.
Zhu.
Dr.
Chen Yuzong
Deputy Director of Center
for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore
All rights reserved.
|
|